Tonix Pharmaceuticals Holding Corp.
TNXP
$12.89
-$0.28-2.09%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/25/2025
-
MarketBeat
9/8/2026
-
TipRanks
9/8/2026
-
Globe Newswire
9/4/2026
-
Tickeron - Stocks
9/2/2026
-
Globe Newswire
9/1/2026
-
Tickeron - Stocks
8/31/2026
-
MarketBeat
8/30/2026
-
The Cerbat Gem
8/29/2026
-
MarketBeat
8/29/2026
-
Tickeron - Stocks
8/26/2026
-
Tickeron - Stocks
8/24/2026
-
MarketBeat
8/18/2026
-
TipRanks
8/18/2026
-
MarketBeat
8/14/2026
-
SeekingAlpha
8/13/2026
-
Simply Wall St
8/12/2026
-
Simply Wall St
8/10/2026
-
Seeking Alpha: Transcripts
8/10/2026
-
SeekingAlpha
8/10/2026
-
MarketBeat
8/10/2026
-
MarketBeat
8/10/2026
-
Globe Newswire
8/8/2026
-
Simply Wall St
Tonix Pharmaceuticals Holding (TNXP, $12.03) Aroon Indicator entered a Downtrend on August 07, 2026.
8/8/2026
-
Tickeron - Stocks
1/30/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
862 799 8599
Address
200 Connell Drive
Suite 3100
Berkeley Heights, NJ 07928
Suite 3100
Berkeley Heights, NJ 07928
Country
Year Founded
Business Description
Sector
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and...
more